AU661018B2 - Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents - Google Patents
Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agentsInfo
- Publication number
- AU661018B2 AU661018B2 AU22889/92A AU2288992A AU661018B2 AU 661018 B2 AU661018 B2 AU 661018B2 AU 22889/92 A AU22889/92 A AU 22889/92A AU 2288992 A AU2288992 A AU 2288992A AU 661018 B2 AU661018 B2 AU 661018B2
- Authority
- AU
- Australia
- Prior art keywords
- amino
- therapeutic agents
- acid derivatives
- hydroxyhexanoic acid
- further novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- LUMVYMITQCJEGS-UHFFFAOYSA-N 5-amino-4-hydroxyhexanoic acid Chemical class CC(N)C(O)CCC(O)=O LUMVYMITQCJEGS-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Crystallography & Structural Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH268991 | 1991-09-12 | ||
| CH2689/91 | 1991-09-12 | ||
| CH98092 | 1992-03-27 | ||
| CH980/92 | 1992-03-27 | ||
| CH2007/92 | 1992-06-25 | ||
| CH200792 | 1992-06-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2288992A AU2288992A (en) | 1993-03-18 |
| AU661018B2 true AU661018B2 (en) | 1995-07-13 |
Family
ID=27172572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU22889/92A Ceased AU661018B2 (en) | 1991-09-12 | 1992-09-10 | Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0532466A3 (en) |
| JP (1) | JPH05230095A (en) |
| KR (1) | KR930006050A (en) |
| AU (1) | AU661018B2 (en) |
| CA (1) | CA2077948A1 (en) |
| CZ (1) | CZ280292A3 (en) |
| FI (1) | FI924035A7 (en) |
| HU (1) | HUT63632A (en) |
| IL (1) | IL103126A (en) |
| MX (1) | MX9205208A (en) |
| NO (1) | NO923533L (en) |
| NZ (1) | NZ244288A (en) |
| PL (1) | PL169969B1 (en) |
| RU (1) | RU2067585C1 (en) |
| SK (1) | SK280292A3 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU678202B2 (en) * | 1993-03-11 | 1997-05-22 | Novartis Ag | Acyloxyhexanoic acid derivatives |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5643878A (en) * | 1991-09-12 | 1997-07-01 | Ciba-Geigy Corporation | 5-amino-4-hydroxyhexanoic acid derivatives |
| US5888992A (en) * | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
| MXPA93002392A (en) | 1992-03-11 | 2005-02-04 | Narhex Ltd | Amine derivatives of oxo- and hydroxy-substitued hydrocarbons. |
| JPH07504654A (en) * | 1992-03-11 | 1995-05-25 | ナルヘックス リミテッド | Amine derivatives of oxo- and hydroxy-substituted hydrocarbons |
| US6071895A (en) | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
| TW217410B (en) * | 1992-04-01 | 1993-12-11 | Ciba Geigy | |
| DE59303870D1 (en) | 1992-12-23 | 1996-10-24 | Ciba Geigy Ag | Antiretroviral hydrazine derivatives |
| EP0626178A1 (en) * | 1993-05-17 | 1994-11-30 | Ciba-Geigy Ag | Use of inhibitors of HIV-protease for the treatment of tumorous diseases |
| IL110898A0 (en) * | 1993-09-10 | 1994-11-28 | Narhex Australia Pty Ltd | Polar-substituted hydrocarbons |
| IL110752A (en) * | 1993-09-13 | 2000-07-26 | Abbott Lab | Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor |
| US5559158A (en) * | 1993-10-01 | 1996-09-24 | Abbott Laboratories | Pharmaceutical composition |
| IL111991A (en) * | 1994-01-28 | 2000-07-26 | Abbott Lab | Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent |
| AU4117396A (en) * | 1994-11-29 | 1996-06-19 | Novartis Ag | Morpholinoethylamide derivatives |
| US6037157A (en) | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
| US5817757A (en) * | 1995-10-30 | 1998-10-06 | Merck & Co., Inc. | Inhibitors of peptide binding to MHO class II proteins |
| AU7475396A (en) * | 1995-10-30 | 1997-05-22 | Merck & Co., Inc. | Novel inhibitors of peptide binding to mhc class ii proteins |
| US5840835A (en) * | 1995-10-30 | 1998-11-24 | Merck & Co., Inc. | Inhibitors of peptide binding to MHC class II proteins |
| US5914332A (en) | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| US6232333B1 (en) | 1996-11-21 | 2001-05-15 | Abbott Laboratories | Pharmaceutical composition |
| CN1343219A (en) * | 1999-01-28 | 2002-04-03 | 中外制药株式会社 | Substituted phenethylamine derivatives |
| US6455734B1 (en) * | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| KR100708221B1 (en) | 1999-08-31 | 2007-04-17 | 아지노모토 가부시키가이샤 | Method for producing epoxide crystal |
| TR201809435T4 (en) | 2000-01-19 | 2018-07-23 | Abbvie Inc | Improved pharmaceutical formulations. |
| US6506786B2 (en) | 2001-02-13 | 2003-01-14 | Pharmacor Inc. | HIV protease inhibitors based on amino acid derivatives |
| EA009943B1 (en) * | 2002-11-01 | 2008-04-28 | Вирофарма Инкорпорейтед | Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| US7388008B2 (en) | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
| ES2452718T3 (en) | 2005-11-30 | 2014-04-02 | Taimed Biologics, Inc. | Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation |
| BRPI0707302B8 (en) | 2006-01-27 | 2021-05-25 | Fibrogen Inc | cyanoisoquinoline compounds that act on tissue damage associated with ischemia, hypoxia and anemia, as well as pharmaceutical composition comprising them |
| BRPI0710527B8 (en) | 2006-04-04 | 2021-05-25 | Fibrogen Inc | pyrrolo- and thiazolo-pyridine compounds and pharmaceutical composition comprising them |
| CA2664118A1 (en) | 2006-09-21 | 2008-07-03 | Ambrilia Biopharma Inc. | Protease inhibitors |
| JP5649584B2 (en) | 2008-11-14 | 2015-01-07 | フィブロジェン インコーポレイテッド | Thiochromene derivatives as HIF hydroxylase inhibitors |
| AU2014209319B2 (en) | 2013-01-24 | 2018-04-19 | Fibrogen, Inc. | Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid |
| CN115466316A (en) * | 2021-06-10 | 2022-12-13 | 首都医科大学 | Migration-inhibiting 1-imidazole-beta-carboline-3-formyl-RGDF, preparation, anti-cancer metastasis effect and application |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5126326A (en) * | 1989-06-06 | 1992-06-30 | Bio-Mega, Inc. | Enzyme inhibiting peptide derivatives |
-
1992
- 1992-09-03 EP EP19920810678 patent/EP0532466A3/en not_active Ceased
- 1992-09-07 JP JP4238424A patent/JPH05230095A/en active Pending
- 1992-09-09 KR KR1019920016530A patent/KR930006050A/en not_active Withdrawn
- 1992-09-09 FI FI924035A patent/FI924035A7/en not_active Application Discontinuation
- 1992-09-10 AU AU22889/92A patent/AU661018B2/en not_active Ceased
- 1992-09-10 IL IL103126A patent/IL103126A/en not_active IP Right Cessation
- 1992-09-10 CA CA002077948A patent/CA2077948A1/en not_active Abandoned
- 1992-09-10 NZ NZ244288A patent/NZ244288A/en unknown
- 1992-09-11 NO NO92923533A patent/NO923533L/en unknown
- 1992-09-11 PL PL92295905A patent/PL169969B1/en unknown
- 1992-09-11 HU HU9202925A patent/HUT63632A/en unknown
- 1992-09-11 CZ CS922802A patent/CZ280292A3/en unknown
- 1992-09-11 MX MX9205208A patent/MX9205208A/en not_active IP Right Cessation
- 1992-09-11 RU SU925052915A patent/RU2067585C1/en active
- 1992-09-11 SK SK2802-92A patent/SK280292A3/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU678202B2 (en) * | 1993-03-11 | 1997-05-22 | Novartis Ag | Acyloxyhexanoic acid derivatives |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2288992A (en) | 1993-03-18 |
| CZ280292A3 (en) | 1994-01-19 |
| CA2077948A1 (en) | 1993-03-13 |
| EP0532466A3 (en) | 1993-06-16 |
| SK280292A3 (en) | 1995-02-08 |
| MX9205208A (en) | 1993-03-01 |
| RU2067585C1 (en) | 1996-10-10 |
| JPH05230095A (en) | 1993-09-07 |
| FI924035A7 (en) | 1993-03-13 |
| PL169969B1 (en) | 1996-09-30 |
| KR930006050A (en) | 1993-04-20 |
| HUT63632A (en) | 1993-09-28 |
| IL103126A (en) | 1997-09-30 |
| FI924035A0 (en) | 1992-09-09 |
| IL103126A0 (en) | 1993-02-21 |
| PL295905A1 (en) | 1993-05-17 |
| HU9202925D0 (en) | 1992-11-30 |
| NZ244288A (en) | 1995-03-28 |
| EP0532466A2 (en) | 1993-03-17 |
| NO923533L (en) | 1993-03-15 |
| NO923533D0 (en) | 1992-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU661018B2 (en) | Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents | |
| AU1803092A (en) | 7-azaisoindolinyl-quinolone- and-naphthyridonecarboxylic acid derivatives | |
| AU7122291A (en) | 3-arylcarbonyl-1h-indoles useful as therapeutic agents | |
| AU1739192A (en) | 7-isoindolinyl-quinolone- and -naphthyridonecarboxylic acid derivatives | |
| AU3105493A (en) | Quinolone- and naphthyridone-carboxylic acid derivatives | |
| AU1025792A (en) | Amino acid derivatives | |
| AU4566589A (en) | Beta-amino-boronic acid derivatives | |
| AU5184193A (en) | Diaminobenzoic acid derivatives | |
| AU3020595A (en) | Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments | |
| IL103538A0 (en) | Quinoxaline-carboxylic and-phosphonic acid derivatives | |
| AU7184994A (en) | Imidazole derivatives as therapeutic agents | |
| AU1308988A (en) | Therapeutic compositions | |
| AU646596B2 (en) | Substituted imidazolyl-propenoic acid derivatives | |
| AU3108293A (en) | Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives | |
| AU646762B2 (en) | Cyclic-substituted imidazolyl-propenoic acid derivatives | |
| AU6892291A (en) | 4-hydroxyquinaldic acid derivatives | |
| AU646977B2 (en) | Imidazolyl-propenoic acid derivatives | |
| AU2979892A (en) | Thiazolyl-substituted quinolylmethoxphenylacetic acid derivatives | |
| HU9302728D0 (en) | Pyridazinone-acetic acid derivatives | |
| AU3376993A (en) | Sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives | |
| ZA926938B (en) | Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents | |
| AU1761192A (en) | 3-amino-5-arylpyrazole-4-acetic acid derivatives exhibiting therapeutic effects | |
| AU2841392A (en) | Amino acid derivatives | |
| AU1509492A (en) | Novel thienyl-nonatetraenoic acid derivatives | |
| AU5517890A (en) | Mevinic acid derivatives |